Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Market Cap	138.27M
Revenue (ttm)	209.44M
Net Income (ttm)	12.41M
Shares Out	221.23M
EPS (ttm)	0.04
PE Ratio	15.21
Forward PE	n/a
Dividend	0.03 (4.00%)
Ex-Dividend Date	Jun 25, 2025

Volume	138,000
Average Volume	238,385
Open	0.6400
Previous Close	0.6250
Day's Range	0.6150 - 0.7000
52-Week Range	0.5800 - 0.8000
Beta	0.29
RSI	49.13
Earnings Date	May 13, 2025

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu...

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 205
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: RHONEMA

Financial Performance

In 2024, Rhone Ma Holdings Berhad's revenue was 211.41 million, an increase of 4.17% compared to the previous year's 202.93 million. Earnings were 12.31 million, an increase of 1.87%.